Related Experiment Videos

Histamine H2 receptors mediate morphine-induced locomotor hyperactivity of the C57BL/6J mouse

Behavioral Neuroscience
|February 1, 1986
PubMed

Insights

Histamine H2 receptors in the brain may play a role in morphine-induced hyperactivity in mice. Blocking these receptors in specific brain regions reduced the stimulant effects of morphine.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Opioid drugs like morphine cause hyperactivity in mice.
  • The exact brain mechanisms underlying this effect are not fully understood.

Purpose of the Study:

  • To investigate the role of histamine receptors in morphine-induced locomotor hyperactivity.
  • To determine if blocking histamine H1 or H2 receptors affects opioid-stimulated movement.

Main Methods:

  • Intracranial injections of antihistamines (cimetidine, chlorpheniramine) and naloxone were administered to C57BL/6J mice.
  • Injections targeted specific brain regions (nucleus accumbens/stria terminalis) or the ventricles.
  • Locomotor activity was measured following drug administration.

Main Results:

  • Cimetidine (H2 receptor blocker) injected into the nucleus accumbens/stria terminalis significantly reduced morphine-induced locomotion.
  • Ventricular cimetidine injections did not affect morphine or amphetamine hyperactivity.
  • Chlorpheniramine (H1 receptor blocker) did not reduce morphine-induced locomotion.
  • Naloxone, an opiate antagonist, blocked morphine-induced locomotion.

Conclusions:

  • Histamine H2 receptors, particularly in the nucleus accumbens or adjacent areas, may partially mediate morphine-stimulated locomotion in C57BL/6J mice.
  • Histamine H1 receptors do not appear to play a significant role in this specific behavioral response.

Related Concept Videos